Your browser doesn't support javascript.
loading
The spin trap reagent PBN attenuates degeneration of 5-HT neurones in rat brain induced by p-chloroamphetamine but not fenfluramine.
Murray, T K; Williams, J L; Misra, A; Colado, M I; Green, A R.
Afiliación
  • Murray TK; Astra Neuroscience Research Unit, London, U.K.
Neuropharmacology ; 35(11): 1615-20, 1996.
Article en En | MEDLINE | ID: mdl-9025109
Dark Agouti rats injected with either p-chloroamphetamine (PCA; 2.5 mg/kg i.p.) or fenfluramine (15 mg/kg i.p.) had substantial decreases (approximately 50%) in the concentration of 5-HT and 5-HIAA and binding of [3H]paroxetine in the cerebral cortex 7 days later. This indicates that both compounds had produced neurodegeneration of 5-HT axon terminals. Two doses of alpha-phenyl-N-tert-butyl nitrone (PBN; 150 mg/kg i.p.) 130 min apart had no effect on cortical 5-HT content or [3H]paroxetine binding. However, when PBN (150 mg/ kg) was given 10 min before and 120 min after PCA (2.5 mg/kg) it attenuated the PCA-induced neurodegeneration. In contrast, PBN was without significant effect on the fenfluramine-induced damage. Changes in rectal temperature following either the neurotoxins or neurotoxins+ PBN were no more than +/-1 degree C of saline-injected control rats. These data indicate that PCA, like MDMA, probably induces neurotoxic degeneration because of the formation of catechol or quinone metabolites and subsequent reactive tree radical formation. Such a mechanism does not appear to explain fenfluramine-induced damage to 5-HT neurones.
Asunto(s)
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Serotonina / Degeneración Nerviosa / Neuronas / Óxidos de Nitrógeno Límite: Animals Idioma: En Revista: Neuropharmacology Año: 1996 Tipo del documento: Article Pais de publicación: Reino Unido
Buscar en Google
Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Encéfalo / Serotonina / Degeneración Nerviosa / Neuronas / Óxidos de Nitrógeno Límite: Animals Idioma: En Revista: Neuropharmacology Año: 1996 Tipo del documento: Article Pais de publicación: Reino Unido